Your browser doesn't support javascript.
loading
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.
Yi, Taolin; Elson, Paul; Mitsuhashi, Masato; Jacobs, Barbara; Hollovary, Emese; Budd, Thomas G; Spiro, Timothy; Triozzi, Pierre; Borden, Ernest C.
Affiliation
  • Yi T; Taussig Cancer Institute, The Cleveland Clinic, Cleveland, OH, USA.
Oncotarget ; 2(12): 1155-64, 2011 Dec.
Article in En | MEDLINE | ID: mdl-22201704

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon-alpha / Antimony Sodium Gluconate / Drug Therapy, Combination Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncotarget Year: 2011 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon-alpha / Antimony Sodium Gluconate / Drug Therapy, Combination Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncotarget Year: 2011 Document type: Article Affiliation country: United States